FDA investigates Abbott infant formula after reports of illness and one death
date:Feb 23, 2022
d negative for Salmonella Newport, says Vicky Assardo, senior director, global public affairs, Abbott Nutrition.

The FDAs statement outlines the regulator initiated an onsite inspection at the facility.

Findings to date include several positive Cronobacter sakazakii results from environmental samples taken by the FDA and adverse inspectional observations by the FDA investigators.

Assardo stipulates that no distributed product has tested positive for the presence of either of these bacteria,
4/12 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 03:51